Amen. Cancer is the reason I am as deep in this company as I am. Both financially and emotionally. We need to remember the enourmous potential that we have in this area. Right now it's easier to focus on COVID, but if we are successful in cancer the impact will be much greater over the course of time.

I maintain that an approval for COVID is the greatest accelerant that we could possibly have for the advancement of this medicine for all other indications.

As frustrating as this process it, and as maddending as the missteps can be. Let's not forget that Cytodyn is knocking on the door. This little company, in my opinion, has a chance to change the world.